Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Triple-blinded, Placebo-controlled, Parallel Group Study, to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

NCT06103994 is registered in ClinicalTrials.gov with The Archer-Daniels-Midland Company as lead sponsor.

NCT NCT06103994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06103994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Triple-blinded, Placebo-controlled, Parallel Group Study, to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
Lead sponsor
The Archer-Daniels-Midland Company
Phase
Not applicable
Overall status
Completed
Start date
October 27, 2023
Completion date
January 12, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza